Fundraising Fox

Peter Svennilson

Investor

Managing Partner at The Column Group · Board director at NGM Bio · Board director at Neurona Therapeutics · Board director at Ngm Biopharmaceuticals

San Francisco, California

Writes $100K – $5M checks · typically $1.5M

About

Peter Svennilson led Aragon to a ~$1B J&J sale and chaired Seragon to a Genentech/Roche exit; as an Institute for Advanced Study Trustee he links theoretical science with translational creation.

Contact· self-published, not guessed

Invests in

BiotechHealthtech

Board director at NGM Bio

Intro paths

In turn, Peter can intro founders to NGM Bio's investors below.

Board director at Neurona Therapeutics

Intro paths

In turn, Peter can intro founders to Neurona Therapeutics's investors below.

Co-founders at Neurona Therapeutics

CNCory Nicholas
Cory NicholasExecutive Officer, Director, Promoter

Board director at Ngm Biopharmaceuticals

Intro paths

In turn, Peter can intro founders to Ngm Biopharmaceuticals's investors below.

Co-founders at Ngm Biopharmaceuticals

JC
Jin-Long ChenExecutive Officer, Director

Experience

  1. The Column GroupManaging Partner and Foundercurrent2007 — presentSan Francisco Bay Area
  2. Three Crowns CapitalManaging Partner and Founder1996 — 2006

Deals · 3

Circle PharmaBoard seat

via The Column Group · filed Jun 2021 · $66.3M raise

Constellation PharmaBoard seat

via The Column Group · filed Apr 2018 · $100M raise

Ngm BiopharmaceuticalsBoard seat

via The Column Group · filed Feb 2015 · $60M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at The Column Group

Frequently asked questions

Who is Peter Svennilson?
Peter Svennilson led Aragon to a ~$1B J&J sale and chaired Seragon to a Genentech/Roche exit; as an Institute for Advanced Study Trustee he links theoretical science with translational creation.
Where does Peter Svennilson work?
Peter Svennilson is Managing Partner at The Column Group and Board director at NGM Bio and Board director at Neurona Therapeutics and Board director at Ngm Biopharmaceuticals.
What does Peter Svennilson invest in?
Peter Svennilson invests in Biotech, Healthtech.
What check size does Peter Svennilson write?
Peter Svennilson typically writes checks of $100K – $5M.
What boards does Peter Svennilson sit on?
Peter Svennilson holds tracked board seats at Circle Pharma, Constellation Pharma, Ngm Biopharmaceuticals.
Where did Peter Svennilson go to school?
Peter Svennilson studied at Stockholm School of Economics (Master of Business Administration (MBA), Business Administration and Management); London Business School (Studies at MBA Program); INSEAD (Studies at MBA Program).

Same school